Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2011; 17(34): 3899-3911
Published online Sep 14, 2011. doi: 10.3748/wjg.v17.i34.3899
Published online Sep 14, 2011. doi: 10.3748/wjg.v17.i34.3899
Figure 4 Analysis by flow cytometry of HepG2 cells apoptosis (annexin V) and of mitochondrial functionality (JC-1).
Cells treated with dimethyl sulfoxide (DMSO) (24 h), or pretreated with buthionine sulfoximine (BSO) (24 h) and then cotreated with azathioprine (AZA) (24 h) in absence or presence of N-acetylcysteine (NAC). This experiment is representative of three others with similar results.
- Citation: Hernández-Breijo B, Monserrat J, Ramírez-Rubio S, Cuevas EP, Vara D, Díaz-Laviada I, Fernández-Moreno MD, Román ID, Gisbert JP, Guijarro LG. Preclinical evaluation of azathioprine plus buthionine sulfoximine in the treatment of human hepatocarcinoma and colon carcinoma. World J Gastroenterol 2011; 17(34): 3899-3911
- URL: https://www.wjgnet.com/1007-9327/full/v17/i34/3899.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i34.3899